Clinical Trial Update: Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study（TOPS-CSVD） [Phase 4]

View source ↗

Summary

Phase 4 randomized trial update for Tongxinluo Capsule in cerebral small vessel disease; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Small Vessel Diseases

Drugs mentioned

• Tongxinluo Capsule

Snippet

Sponsor: Fudan University | Conditions: Cerebral Small Vessel Diseases | Phase 4 | Status: NOT_YET_RECRUITING